CD39 is an ectoenzyme converting pro-inflammatory ATP to immunosuppressive adenosine which is expressed on Treg and exhausted conventional CD8+ T cells [41], and this way exhausted MAIT cells may contribute directly to reducing anti-tumor immunity. Here, ENTPD1 is linked to neoplasm.